| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |